A Study of Baricitinib (LY3009104) in Participants With Severe or Very Severe Alopecia Areata
Clinical trial NCT03570749 · COMPLETED
Trial details
- NCT number
- NCT03570749
- Sponsor
- Eli Lilly and Company
- Status
- COMPLETED
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2018-09-24
- Primary completion
- 2021-02-02
- Enrollment
- 784
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.